Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy

NCT01854593 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Proliferative Diabetic Retinopathy
Diabetic Traction Retinal Detachment
Vitreous Hemorrhage

Interventions

DRUG: Bevacizumab
PROCEDURE: Vitrectomy
DEVICE: Sham injection

Sponsor

Nihon University